Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

被引：0
|
作者：
Brooke Harrow
Francis Fagnani
Camille Nevoret
Xuan-Mai Truong-Thanh
Marie de Zélicourt
Louis de Mestier
机构：
[1] Ipsen,Department of Gastroenterology
[2] CEMKA,Pancreatology, Beaujon Hospital (APHP)
[3] Ipsen,undefined
[4] Université de Paris,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
GEP-NETs; Lanreotide; Neuroendocrine tumors; Octreotide; Real-world; Somatostatin analogues; SNDS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1754 / 1771
页数：17
相关论文
共 4 条
  • [1] Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
    Harrow, Brooke
    Fagnani, Francis
    Nevoret, Camille
    Truong-Thanh, Xuan-Mai
    de Zelicourt, Marie
    de Mestier, Louis
    ADVANCES IN THERAPY, 2022, 39 (04) : 1754 - 1771
  • [2] Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study
    Ranallo, Nicoletta
    Roncadori, Andrea
    Gentili, Nicola
    Balzi, William
    Altini, Mattia
    Ghini, Virginia
    Maltoni, Roberta
    Andalo, Alice
    Cavallucci, Martina
    Sansovini, Maddalena
    Fausti, Valentina
    Montella, Maria Teresa
    Massa, Ilaria
    Danesi, Valentina
    BIOMEDICINES, 2025, 13 (02)
  • [3] Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
    Wolin, Edward M.
    Jarzab, Barbara
    Eriksson, Barbro
    Walter, Thomas
    Toumpanakis, Christos
    Morse, Michael A.
    Tomassetti, Paola
    Weber, Matthias M.
    Fogelman, David R.
    Ramage, John
    Poon, Donald
    Gadbaw, Brian
    Li, Jiang
    Pasieka, Janice L.
    Mahamat, Abakar
    Swahn, Fredrik
    Newell-Price, John
    Mansoor, Wasat
    Oeberg, Kjell
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5075 - 5086
  • [4] Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
    Antonio Bianchi
    Ferdinando Valentini
    Raffaella Iuorio
    Maurizio Poggi
    Roberto Baldelli
    Marina Passeri
    Antonella Giampietro
    Linda Tartaglione
    Sabrina Chiloiro
    Marialuisa Appetecchia
    Patrizia Gargiulo
    Andrea Fabbri
    Vincenzo Toscano
    Alfredo Pontecorvi
    Laura De Marinis
    Journal of Experimental & Clinical Cancer Research, 32
1